|
|
Blood, 15 June 2008, Vol. 111, No. 12, pp. 5562-5570.
Prepublished online as a Blood First Edition Paper on April 18, 2008; DOI 10.1182/blood-2007-11-126219.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS AND STEM CELLS
Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages
Holger Karsunky1,
Matthew A. Inlay1,
Thomas Serwold1,
Deepta Bhattacharya1, and
Irving L. Weissman1
1 Institute of Stem Cell Biology and Regenerative Medicine at Stanford University, Departments of Pathology and Developmental Biology, Stanford University School of Medicine, CA
Mature blood cells develop from multipotent hematopoietic stem cells through a series of sequential intermediates in which the developmental potential for particular blood lineages is progressively extinguished. We previously reported the identification of one of these developmental intermediates, the common lymphoid progenitor (CLP), which can give rise to T cells, B cells, dendritic cells (DCs), and natural killer cells (NKs), but lacks myeloid and erythroid potential. Recently, several studies have suggested that the T-cell and DC potential of CLP is limited or absent, and/or that CLP contains significant myeloid potential. Here, we show that the originally identified CLP population can be divided into functionally distinct subsets based on the expression of the tyrosine kinase receptor, Flk2. The Flk2+ subset contains robust in vivo and in vitro T-cell, B-cell, DC, and NK potential, but lacks myeloid potential and, therefore, represents an oligopotent, lymphoid-restricted progenitor. This population of cells does not appear to be B cell–biased and robustly reconstitutes both B and T lineages in vivo, consistent with its being a physiologic progenitor of both of these subsets. Thus, Flk2 expression defines a homogeneous, readily obtainable subset of bone marrow CLP that is completely lymphoid-committed and can differentiate equivalently well into both B and T lineages.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. A. Inlay, D. Bhattacharya, D. Sahoo, T. Serwold, J. Seita, H. Karsunky, S. K. Plevritis, D. L. Dill, and I. L. Weissman
Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development
Genes & Dev.,
October 15, 2009;
23(20):
2376 - 2381.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Weber, A. Krueger, A. Munk, C. Bode, P. P. Van Veldhoven, and M. H. Graler
Discontinued Postnatal Thymocyte Development in Sphingosine 1-Phosphate-Lyase-Deficient Mice
J. Immunol.,
October 1, 2009;
183(7):
4292 - 4301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cheng, H. N. Charoudeh, P. Brodin, Y. Tang, T. Lakshmikanth, P. Hoglund, S. E. W. Jacobsen, and E. Sitnicka
Distinct and Overlapping Patterns of Cytokine Regulation of Thymic and Bone Marrow-Derived NK Cell Development
J. Immunol.,
February 1, 2009;
182(3):
1460 - 1468.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. Bunting
CLPs find their inner T-cell potential
Blood,
January 22, 2009;
113(4):
766 - 767.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Serwold, L. I. Richie Ehrlich, and I. L. Weissman
Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis
Blood,
January 22, 2009;
113(4):
807 - 815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. L. Weissman and J. A. Shizuru
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
Blood,
November 1, 2008;
112(9):
3543 - 3553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
